Managing fear of cancer recurrence in survivors through a stepped-care intervention

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness of a stepped-care metacognition-based intervention designed to help cancer survivors manage their fear of cancer recurrence (FCR). Using a sequential multiple-assignment randomized controlled trial (SMART) design, participants will receive different interventions based on their responses, starting with eConquerFear or eHealthMaintenance. The study aims to determine the best initial intervention and the most effective subsequent strategies for those who do not respond initially. The focus is on reducing FCR through adaptive interventions that address maladaptive metacognition and cognitive attentional syndrome.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynecological cancer, who had completed treatment (except endocrine therapy) within five years, and with a Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF) score of 13 to 21 indicating subclinical FCR will be included.

Exclusion Criteria:

* Patients with metastatic cancer, with a current diagnosis of depression or psychosis, or who are already receiving psychological treatment will be excluded.

Where it's running

• QMh department of surgery
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Wendy Lam, PhD — School of Public Health, The University of Hong Kong
• Study coordinator: Danielle Ng, PhD
• Email: dwlng@hku.hk
• Phone: +852 39179897

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Patient-partnered look at fear of cancer returning after kidney cancer surgery

  This project will work with people who had kidney cancer surgery and their partners to see if patient-led questions, timing, and digital methods can better identify fear that the cancer will come back.

  Recruiting at 3 sites Gødstrup Hospital · Aalborg and 2 other locations · NCT07234656

• Parent-FORT: Fear of Cancer Recurrence therapy for parents of childhood cancer survivors

  This pilot tests a virtual group therapy called Parent-FORT to see if it reduces fear of cancer recurrence and improves quality of life for parents of childhood cancer survivors.

  Recruiting University of Ottawa · Ottawa, Ontario · NCT06872840

• Adapted group cognitive-behavioral therapy for fear of cancer returning in women with BRCA1 or BRCA2 mutations

  This project tests an adapted group cognitive-behavioral therapy to reduce fear of cancer returning in women who carry BRCA1 or BRCA2 mutations and have finished primary treatment.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT06817694

• EMDR treatment for fear of cancer recurrence in familial melanoma patients

  This study is testing if EMDR therapy can help patients with familial melanoma feel less afraid of their cancer coming back.

  Recruiting at 2 sites Leiden University Medical Center · Leiden, South Holland and 1 other locations · NCT06767332

• Program to manage fear of cancer recurrence in patients

  This study is testing a new program to help cancer patients manage their fear of cancer coming back by providing better support in clinics.

  Recruiting at 2 sites The University of Hong Kong · Hong Kong and 1 other locations · NCT06181344

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.